Clinical trialNCT02563522TerminatedPhase 3Interventional

Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot Ulcers

SponsorHelixmith Co., Ltd.Enrollment44Foot Ulcer, Diabetic

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will assess the safety and efficacy of using gene therapy via intramuscular injections of the calf for patients with chronic non-healing foot ulcers.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David G Armstrong,, DPM, MD, PhD
Keck School of Medicine of University of Southern California
Principal Investigator
clinicaltrials.gov ↗
Emerson C. Perin, MD
Texas Heart Institute
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Central Research Associates, Inc.
Birmingham, Alabama, United States
Arizona Research Center
Phoenix, Arizona, United States
University of Arizona
Tucson, Arizona, United States
Nea Baptist
Jonesboro, Arkansas, United States
Sacramento Foot and Ankle
Carmichael, California, United States
Bay Area Foot and Ankle
Castro Valley, California, United States
Va Long Beach Healthcare System
Long Beach, California, United States
Foot and Ankle Clinic
Los Angeles, California, United States
Usc Keck School of Medicine
Los Angeles, California, United States
Center for Clinical Research Inc.
San Francisco, California, United States
Olive View-Ucla Education & Research Institute
Sylmar, California, United States
Lcc Medical Research Institute
Miami, Florida, United States
Miami Dade Medical Research Institute, Llc
Miami, Florida, United States
Northwestern University
Chicago, Illinois, United States
Umass Memorial Med Center
Worcester, Massachusetts, United States
Saint Louis University
St Louis, Missouri, United States
Advanced Foot & Ankle Center
Las Vegas, Nevada, United States
Oregon Foot and Ankle Center
Eugene, Oregon, United States
Medresearch, Inc
El Paso, Texas, United States
Acclaim Bone & Joint Institute
Fort Worth, Texas, United States
Texas Heart Institute
Houston, Texas, United States
Futuro Clinical Trials
McAllen, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Jun 2017
Primary completion: 24 Sept 2019
Completion: 24 Sept 2019
Last update posted: 9 Oct 2025
Registered enrollment: 44
Registry id: NCT02563522

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.